We can't find evidence that holds up here. Proponents are reasoning from mechanism or analogy rather than direct human data, and the most credible skeptics raise objections we can't dismiss.
what do they show they show that in this placebo-controlled high-dose long-term study resveratrol treatment had no consistent therapeutic effect in alleviating clinical or histological methyl d and they found that it actually worsened markers of metabolic syndrome it says resveratrol treatment was not associated with improvements in sensitivity or markers of the metabolic syndrome in fact it worsened them in this study and others
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
this is a placebo-controlled randomized clinical trial high-dose resveratrol treatment for non-alcoholic fatty liver disease it failed no consistent therapeutic effect in alleviating clinical or histological nafld
there are many studies that show that in placebo-controlled randomized clinical trials resveratrol fails repeatedly to show improvements at multiple clinical endpoints